It has been also reported an insulin sensitivity recovery through SPT inhibition in high-fat diet (HFD)-induced IR mouse models, which also lead to steatohepatitis and NASH [40,48]. This evidence concerns the gene AGXT and metabolic dysfunction-associated steatohepatitis.